Form 8-K - Current report:
SEC Accession No. 0001213900-21-064566
Filing Date
2021-12-10
Accepted
2021-12-10 08:17:56
Documents
13
Period of Report
2021-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea152105-8k_180life.htm   iXBRL 8-K 35997
  Complete submission text file 0001213900-21-064566.txt   257772

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20211208.xsd EX-101.SCH 3790
3 XBRL DEFINITION FILE atnf-20211208_def.xml EX-101.DEF 26659
4 XBRL LABEL FILE atnf-20211208_lab.xml EX-101.LAB 36698
5 XBRL PRESENTATION FILE atnf-20211208_pre.xml EX-101.PRE 25277
6 EXTRACTED XBRL INSTANCE DOCUMENT ea152105-8k_180life_htm.xml XML 5700
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211483710
SIC: 2834 Pharmaceutical Preparations